Cargando…
Newer fluoroquinolones in the treatment of acute exacerbations of COPD
Acute exacerbations of COPD are a major cause of morbidity and mortality. Bacteria are implicated in about half of all cases. The frequency of exacerbations is related to decline in lung function and poorer quality of life. 25% of patients with COPD have bacterial colonization of the lower airways i...
Autores principales: | Patel, Amit, Wilson, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707162/ https://www.ncbi.nlm.nih.gov/pubmed/18046861 |
Ejemplares similares
-
Skin and skin structure infections: treatment with newer generation fluoroquinolones
por: Giordano, Philip, et al.
Publicado: (2007) -
A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India
por: Hajare, Anoop, et al.
Publicado: (2015) -
In the Quest of Drugs for Bad Bugs: Are Newer Fluoroquinolones Any Better?
por: Deep, Antariksh, et al.
Publicado: (2011) -
Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study
por: Ernst, Pierre, et al.
Publicado: (2019) -
Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)